Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Finished Goods (2016 - 2018)

Apyx Medical (APYX) has disclosed Finished Goods for 3 consecutive years, with $1.1 million as the latest value for Q4 2018.

  • For the quarter ending Q4 2018, Finished Goods rose 10.35% year-over-year to $1.1 million, compared with a TTM value of $1.1 million through Dec 2018, up 10.35%, and an annual FY2018 reading of $1.1 million, up 10.35% over the prior year.
  • Finished Goods was $1.1 million for Q4 2018 at Apyx Medical, up from $1.0 million in the prior quarter.
  • Across five years, Finished Goods topped out at $3.0 million in Q4 2016 and bottomed at $1.0 million in Q4 2017.
  • Average Finished Goods over 3 years is $1.7 million, with a median of $1.1 million recorded in 2018.
  • The sharpest move saw Finished Goods crashed 66.4% in 2017, then increased 10.35% in 2018.
  • Year by year, Finished Goods stood at $3.0 million in 2016, then plummeted by 66.4% to $1.0 million in 2017, then rose by 10.35% to $1.1 million in 2018.
  • Business Quant data shows Finished Goods for APYX at $1.1 million in Q4 2018, $1.0 million in Q4 2017, and $3.0 million in Q4 2016.